Since ku-0063794 at the IC50 concentration effectively inhibited p70S6K phosphorylation levels in both sensitive and resistant NSCLC cells, these results indicated that ku-0063794 may exert greater antitumor effects in tumors that express high levels of total or phosphorylated p70S6K. This evidence concerns the gene RPS6KB1 and non-small cell lung carcinoma.